EUVIMEDEUVIMED entdecken
Crossref

Long-term outcomes in juvenile-onset mycosis fungoides

Rishabh Lohray, Seda Purnak, Auris Huen, Madeleine Duvic, Julia Dai

Journal of the American Academy of Dermatology · 2026-08 · 95 (2) · 409-415

DOI: 10.1016/j.jaad.2026.02.095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-08. Verfasst von Rishabh Lohray und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Dermatology, Baylor College of Medicine, Hous…. Hauptthemen laut MEDLINE: Mycosis Fungoides, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Mycosis fungoides is the most common cutaneous T-cell lymphoma (CTCL) in the pediatric population. OBJECTIVE We aimed to characterize the long-term outcomes associated with juvenile-onset mycosis fungoides (jMF). METHODS Patients were identified from a retrospective database. Clinical and histopathologic data were obtained from medical records, and survival was assessed through contact by telemedicine. Stage progression was defined as progression to a more advanced TNMB stage or death from disease. RESULTS From 1987 to 2023, 118 patients were diagnosed with jMF: 97% of patients (115/118) had early-stage (IA-IIA) disease at diagnosis, and 3% (3/118) had advanced-stage (IIB-IVB) disease. Thirteen percent of patients (15/118 patients) developed disease progression with a median time to progression of 2 years (range: 2 months to 13 years). Median follow-up time for survival assessment was 7.2 years (range: 2 months to 32 years). Overall, 5-year and 10-year survival rates were 99% and 98%, respectively, and 5 and 10-year disease-specific survival rates were 100%. No patients died of disease. LIMITATIONS This is a single-center retrospective study. CONCLUSION jMF often presents with early-stage disease and has an excellent prognosis with a 5-year and 10-year OSS of 99% and of 98%, respectively. Disease progression is uncommon and did not lead to disease-specific death in our cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycosis FungoidesSkin NeoplasmsHumansRetrospective StudiesFemaleChildMaleAdolescentDisease ProgressionChild, PreschoolNeoplasm StagingAge of OnsetSurvival RateFollow-Up StudiesTime FactorsPrognosis

Stichwörter der Autor:innen

cutaneous T-cell lymphomajuvenile-onset mycosis fungoidespediatric

Autor:innen und Institutionen

  • Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Dermatology, Baylor College of Medicine, Houston, Texas.
  • Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: jdai6@mdanderson.org.

Zitieren

APA

Lohray, R., Purnak, S., Huen, A., Duvic, M., & Dai, J. (2026). Long-term outcomes in juvenile-onset mycosis fungoides. Journal of the American Academy of Dermatology, 95(2), 409-415. https://doi.org/10.1016/j.jaad.2026.02.095

Vancouver

Lohray R, Purnak S, Huen A, Duvic M, Dai J. Long-term outcomes in juvenile-onset mycosis fungoides. Journal of the American Academy of Dermatology. 2026;95(2):409-415. doi:10.1016/j.jaad.2026.02.095

BibTeX
@article{Lohray2026,
  author = {Lohray, Rishabh and Purnak, Seda and Huen, Auris and Duvic, Madeleine and Dai, Julia},
  title = {Long-term outcomes in juvenile-onset mycosis fungoides},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {95},
  number = {2},
  pages = {409--415},
  doi = {10.1016/j.jaad.2026.02.095}
}
Kostenlos starten →